口服葡萄糖耐量试验第一时相胰岛素反应指标及其对1型糖尿病的预测能力
在自身抗体阳性1型糖尿病亲属中,评估口服葡萄糖耐量试验指标与静脉葡萄糖耐量试验第一时相胰岛素反应的相关性及对2年1型糖尿病的预测能力。C肽指数在两个研究中均与第一时相胰岛素反应相关性最强;Index60和C肽指数预测准确性最高且相当;口服葡萄糖耐量试验可考虑替代静脉葡萄糖耐量试验用于预防试验分层。
要点
- C肽指数在两个研究中均与第一时相胰岛素反应相关性最强(TN-07 r=0.583,DPT-1 r=0.544)。
- Index60和C肽指数预测1型糖尿病的ROC曲线下面积最高且两者无显著差异。
- 作者认为口服葡萄糖耐量试验可考虑替代静脉葡萄糖耐量试验用于预防试验受试者分层。
核心结论
- C肽指数在两个研究中均是与第一时相胰岛素反应相关性最强的指标。
- Index60和C肽指数对1型糖尿病的预测准确性最高且相当。
- 口服葡萄糖耐量试验可考虑替代静脉葡萄糖耐量试验用于1型糖尿病预防试验的受试者分层。
研究设计与样本
- 在30天内先后进行口服葡萄糖耐量试验和静脉葡萄糖耐量试验,评估11项口服葡萄糖耐量试验指标与第一时相胰岛素反应的相关性及对1型糖尿病的预测能力。
- 研究纳入TN-07研究(n=292;年龄9.4±6.1岁)和DPT-1研究(n=194;年龄15.1±10.0岁)的自身抗体阳性1型糖尿病亲属。
- 主要结局指标为口服葡萄糖耐量试验指标与第一时相胰岛素反应的相关系数,以及用ROC曲线下面积评估的2年1型糖尿病预测能力。
主要发现
- Index60在DPT-1中相关性最强(r=-0.562),但在TN-07中较弱(r=-0.378)。
- C肽指数在两个研究中均与第一时相胰岛素反应显示良好相关性(TN-07 r=0.583;DPT-1 r=0.544;P<0.0001)。
- Index60和C肽指数预测1型糖尿病的ROC曲线下面积最高(TN-07分别为0.778和0.717;DPT-1分别为0.763和0.721;P=NS)。
- 第一时相胰岛素反应的ROC曲线下面积分别为TN-07 0.707和DPT-1 0.628。
临床怎么用
- 作者认为,口服葡萄糖耐量试验可考虑替代静脉葡萄糖耐量试验用于1型糖尿病预防试验的受试者分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Decreased first-phase insulin response (FPIR) during intravenous glucose tolerance testing (IVGTT) is an early indicator of β-cell dysfunction and predictor of type 1 diabetes (T1D). OBJECTIVE: Assess whether oral glucose tolerance test (OGTT) measures could serve as FPIR alternatives in their ability to predict T1D in autoantibody positive (Aab+) subjects. DESIGN: OGTT and IVGTT were performed within 30 days of each other. Eleven OGTT variables were evaluated for (1) correlation with FPIR and (2) T1D prediction. SETTING: Type 1 Diabetes TrialNet "Oral Insulin for Prevention of Diabetes in Relatives at Risk for T1D" (TN-07) and Diabetes Prevention Trial-Type 1 Diabetes (DPT-1) studies clinical sites. PATIENTS: TN-07 (n = 292; age 9.4 ± 6.1 years) and DPT-1 (n = 194; age 15.1 ± 10.0 years) Aab + relatives of T1D individuals. MAIN OUTCOME MEASURES: (1) Correlation coefficients of OGTT measures with FPIR and (2) T1D prediction at 2 years using area under receiver operating characteristic (ROCAUC) curves. RESULTS: Index60 showed the strongest correlation in DPT-1 (r = -0.562) but was weaker in TN-07 (r = -0.378). C-peptide index consistently showed good correlation with FPIR across studies (TN-07, r = 0.583; DPT-1, r = 0.544; P < 0.0001). Index60 and C-peptide index had the highest ROCAUCs for T1D prediction (0.778 vs 0.717 in TN-07 and 0.763 vs 0.721 in DPT-1, respectively; P = NS), followed by FPIR (0.707 in TN-07; 0.628 in DPT-1). CONCLUSIONS: C-peptide index was the strongest measure to correlate with FPIR in both studies. Index60 and C-peptide index had the highest predictive accuracy for T1D and were comparable. OGTTs could be considered instead of IVGTTs for subject stratification in T1D prevention trials.
引用
- Baidal DA, Warnock M, Xu P, et al. Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 Diabetes. J Clin Endocrinol Metab. 2022. PMID: 35524749. doi:10.1210/clinem/dgac285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。